Safety & Efficacy Study of the Adiana System for Women Who Desire Permanent Birth Control (Steril… (NCT00737061) | Clinical Trial Compass
TerminatedNot Applicable
Safety & Efficacy Study of the Adiana System for Women Who Desire Permanent Birth Control (Sterilization)
Stopped: Product Pre-Market Approval withdrawn
United States770 participantsStarted 2002-11
Plain-language summary
The purpose of this study is to demonstrate the safety \& efficacy of the Adiana Transcervical Sterilization System for women who desire permanent birth control (female sterilization) by occlusion of the fallopian tubes.
Who can participate
Age range18 Years – 45 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Women aged 18 to 45
* Women who are seeking permanent contraception
* Women who are at risk of becoming pregnant
* Willing to risk becoming pregnant when relying on the Adiana device for contraception
* Relatively normal uterine cavity, uterine wall thickness, and uterine size as demonstrated by pelvic sonography
* Willing to keep a coital/menstrual log
* Have at least one confirmed pregnancy and one living child
* Monogamous relationship with a partner who has proven fertility
* Sexually active (at least 4 acts of intercourse per month)
* Willing to use alternate contraception (either a barrier method or oral contraceptive pills or other monthly, cyclic, hormonal birth control) during the three months following device placement prior to relying on the Adiana device for contraception
* Willing and able to maintain in regular contact with the investigator
* Women with regular, cyclical menses within 2 months prior to the device placement procedure
* Able to provide informed consent
Exclusion Criteria:
* Women who are unsure of their desire to end their fertility
* Presence of gross genital infection, including sepsis
* Presence of chlamydia, gonorrhea or syphilis
* Presence of genital cancer (note: CIN1 is acceptable)
* Intra-uterine pathology which would prevent optimal access to the tubal ostium and intramural portion of the fallopian tube, such as large submucous fibroids or uterine adhesions
* History of chronic pelvic pa…